Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Telomir Pharmaceuticals, Inc. (TELO) had Weighted-Average Shares Outstanding (Diluted) of 32.40M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.10M |
|
-- |
|
-- |
|
$1.15M |
|
$-1.15M |
|
$0.04M |
|
$-1.10M |
|
$-1.10M |
|
$-1.10M |
|
$-1.10M |
|
$-1.10M |
|
$-1.10M |
|
$-1.15M |
|
$-1.15M |
|
32.40M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
32.40M |
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$7.40M |
|
-- |
|
-- |
|
$7.40M |
|
$0.42M |
|
-- |
|
-- |
|
$0.42M |
|
$6.98M |
|
$6.98M |
|
$6.98M |
|
33.83M |
|
| Cash Flow Statement Financials | |
$-2.49M |
|
-- |
|
$8.55M |
|
$1.27M |
|
$7.33M |
|
$6.06M |
|
$5.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.79% |
|
-15.79% |
|
-14.89% |
|
-15.79% |
|
$0.21 |
|
$-0.08 |
|
$-0.08 |
|